A Livelihood Intervention to Reduce the Stigma of HIV in Rural Kenya: Longitudinal Qualitative Study

AIDS and Behavior
Alexander C TsaiSheri D Weiser

Abstract

The scale-up of effective treatment has partially reduced the stigma attached to HIV, but HIV still remains highly stigmatized throughout sub-Saharan Africa. Most studies of anti-HIV stigma interventions have employed psycho-educational strategies such as information provision, counseling, and testimonials, but these have had varying degrees of success. Theory suggests that livelihood interventions could potentially reduce stigma by weakening the instrumental and symbolic associations between HIV and premature morbidity, economic incapacity, and death, but this hypothesis has not been directly examined. We conducted a longitudinal qualitative study among 54 persons with HIV participating in a 12-month randomized controlled trial of a livelihood intervention in rural Kenya. Our study design permitted assessment of changes over time in the perspectives of treatment-arm participants (N = 45), as well as an understanding of the experiences of control arm participants (N = 9, interviewed only at follow-up). Initially, participants felt ashamed of their seropositivity and were socially isolated (internalized stigma). They also described how others in the community discriminated against them, labeled them as being "already dead," and ...Continue Reading

References

Jul 1, 1987·American Journal of Public Health·J A KellyD J Cook
Nov 1, 1985·Annals of Internal Medicine·B J Cassens
Apr 24, 2001·Psychological Bulletin·R Kurzban, M R Leary
Dec 30, 2004·American Journal of Public Health·Arachu Castro, Paul Farmer
Aug 16, 2008·American Journal of Public Health·William R WolfeMichele Heisler
Oct 15, 2008·Annual Review of Psychology·Elizabeth Levy Paluck, Donald P Green
Jan 30, 2009·PLoS Medicine·Norma C WareDavid R Bangsberg
Apr 17, 2009·AIDS and Behavior·Maribel MuñozSonya Shin
Dec 18, 2010·American Journal of Public Health·Catherine CampbellConstance Nyamukapa
Jul 20, 2011·The New England Journal of Medicine·Myron S CohenUNKNOWN HPTN 052 Study Team
May 22, 2013·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Alexander C TsaiSheri D Weiser
Nov 28, 2013·Journal of the International AIDS Society·Ingrid T KatzAlexander C Tsai
Dec 10, 2013·PLoS Medicine·Alexander C TsaiSheri D Weiser
Jan 22, 2014·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Davies O KimangaUNKNOWN KAIS Study Group
Feb 7, 2014·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Sae TakadaAlexander C Tsai
Aug 12, 2014·The Lancet Global Health·Julie Pulerwitz, John Bongaarts
Jun 13, 2015·American Journal of Public Health·Brian T ChanMark J Siedner
Sep 19, 2015·Sociology of Health & Illness·Steve RussellJanet Seeley
Oct 31, 2015·Journal of Health Economics·Victoria BaranovHans-Peter Kohler

❮ Previous
Next ❯

Citations

Jun 21, 2017·Journal of the International AIDS Society·Jessica E HabererDavid R Bangsberg
Feb 12, 2017·AIDS and Behavior·Habib O RamadhaniJohn A Bartlett
Sep 14, 2016·SAHARA J : Journal of Social Aspects of HIV/AIDS Research Alliance·Bernard KakuhikireAlexander C Tsai
Jul 7, 2018·Frontiers in Public Health·Laura NybladeMaria L Ekstrand
Dec 14, 2018·AIDS and Behavior·Jennifer Manne-GoehlerTill W Bärnighausen
Apr 11, 2020·Journal of the International Association of Providers of AIDS Care·Farshid ShamsaeiEfat Sadeghian
Apr 21, 2017·American Journal of Public Health·Bulent TuranJanet M Turan
Dec 8, 2020·Journal of the International AIDS Society·Carol S CamlinDiane V Havlir

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.